Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.: Hormone therapy and venous thromboembolism

Abstract : Oral estrogen therapy increases venous thromboembolism risk among postmenopausal women. Although recent data showed transdermal estrogens may be safe with respect to thrombotic risk, the impact of the route of estrogen administration and concomitant progestogens is not fully established. We used data from the E3N French prospective cohort of women born between 1925 and 1950 and biennially followed by questionnaires from 1990. Study population consisted of 80 308 postmenopausal women (average follow-up: 10.1 years) including 549 documented idiopathic first venous thromboembolism. Hazard ratios (HR) and 95% confidence intervals (CI) were estimated using Cox proportional models. Compared to never-users, past-users of hormone therapy had no increased thrombotic risk (HR=1.1; 95% CI: 0.8 to 1.5). Oral not transdermal estrogens were associated with increased thrombotic risk (HR=1.7; 95% CI: 1.1 to 2.8 and HR=1.1; 95% CI: 0.8 to 1.8; homogeneity: P=0.01). The thrombotic risk significantly differed by concomitant progestogens type (homogeneity: P<0.01): there was no significant association with progesterone, pregnanes, and nortestosterones (HR=0.9; 95% CI: 0.6 to 1.5, HR=1.3; 95% CI: 0.9 to 2.0 and HR=1.4; 95% CI: 0.7 to 2.4). However, norpregnanes were associated with increased thrombotic risk (HR=1.8; 95% CI: 1.2 to 2.7). In this large study, we found that route of estrogen administration and concomitant progestogens type are 2 important determinants of thrombotic risk among postmenopausal women using hormone therapy. Transdermal estrogens alone or combined with progesterone might be safe with respect to thrombotic risk.
Type de document :
Article dans une revue
Arteriosclerosis, Thrombosis, and Vascular Biology, American Heart Association, 2010, 30 (2), pp.340-5. 〈10.1161/ATVBAHA.109.196022〉
Liste complète des métadonnées

Littérature citée [37 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-01142846
Contributeur : Pascale Sztajnbok <>
Soumis le : jeudi 16 avril 2015 - 10:11:20
Dernière modification le : jeudi 11 janvier 2018 - 06:21:02
Document(s) archivé(s) le : lundi 14 septembre 2015 - 09:36:55

Fichier

Canonico_ATVB_2010.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Marianne Canonico, Agnès Fournier, Laure Carcaillon, Valérie Olié, Geneviève Plu-Bureau, et al.. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.: Hormone therapy and venous thromboembolism. Arteriosclerosis, Thrombosis, and Vascular Biology, American Heart Association, 2010, 30 (2), pp.340-5. 〈10.1161/ATVBAHA.109.196022〉. 〈inserm-01142846〉

Partager

Métriques

Consultations de la notice

292

Téléchargements de fichiers

239